Cargando…
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study
BACKGROUND: Current guidelines recommend the use of the lateral flow urine lipoarabinomannan assay (LAM) in HIV-positive, ambulatory patients with signs and symptoms of tuberculosis (TB) only if they are seriously ill or have CD4 count ≤ 100 cells/μl. We assessed the diagnostic yield of including LA...
Autores principales: | Huerga, Helena, Mathabire Rucker, Sekai Chenai, Cossa, Loide, Bastard, Mathieu, Amoros, Isabel, Manhiça, Ivan, Mbendera, Kuzani, Telnov, Alex, Szumilin, Elisabeth, Sanchez-Padilla, Elisabeth, Molfino, Lucas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490904/ https://www.ncbi.nlm.nih.gov/pubmed/31039161 http://dx.doi.org/10.1371/journal.pmed.1002792 |
Ejemplares similares
-
Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients
por: Huerga, Helena, et al.
Publicado: (2020) -
Urine Lipoarabinomannan Testing for All HIV Patients Hospitalized in Medical Wards Identifies a Large Proportion of Patients With Tuberculosis at Risk of Death
por: Huerga, Helena, et al.
Publicado: (2020) -
Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi
por: Huerga, Helena, et al.
Publicado: (2020) -
Feasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions: a multisite study
por: Mathabire Rucker, Sekai Chenai, et al.
Publicado: (2019) -
Transmission of COVID-19 among healthcare workers-an epidemiological study during the first phase of the pandemic in Sweden
por: Mathabire Rücker, Sekai Chenai, et al.
Publicado: (2022)